The PI3k pathway represents an attractive target for drug development in melanoma, as numerous studies have shown that this pathway is active in malignant melanocytes. In addition, previous work has shown that multi-level targeting of this pathway might be more effective than targeting the pathway at a single level. In this review, we discuss targeting different members of this pathway, potential escape mechanisms, classes of specific molecular inhibitors, and development of NVP-BEZ235, a novel dual PI3k/mTOR inhibitor.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1568009611313020006 | DOI Listing |
Publication Analysis
Top Keywords
targeting pathway
8
pathway
5
studies nvp-bez235
4
nvp-bez235 melanoma
4
melanoma pi3k
4
pi3k pathway
4
pathway represents
4
represents attractive
4
attractive target
4
target drug
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!